This month’s feature article is the first publication of the top 15 drug companies in the 2015 global industry ranking and how this has changed over the last decade. In trying to analyse the changes that have taken place, we have looked at different strategies used by management teams. Many companies are featured, but there is emphasis on GlaxoSmithKline (GSK), AstraZeneca (AZN) and Shire Pharmaceuticals (SHP). In addition, we have analysed how drugs derived from antibodies have driven market growth and now represent just over 10% of annual industry sales.
08 Mar 2016
Hardman Monthly – March 2016
Allergy Therapeutics plc (AGY:LON), 2.8 | Alliance Pharma plc (APH:LON), 35.8 | Software Circle PLC (SFT:LON), 19.0 | Lombard Risk Management (LRM:LON), 0 | Medicx Fund (MXF:LON), 0 | Murgitroyd Group (MUR:LON), 0 | PPHE Hotel Group Limited (PPH:LON), 1,452 | R.E.A. Holdings plc (RE:LON), 72.0 | Redx Pharma Plc (REDX:LON), 10.2 | Tissue Regenix Group plc (TRX:LON), 61.5 | United Cacao Ltd Sezc (CHOC:LON), 0 | Primary Health Properties PLC (PHP:LON), 93.0 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Avacta Group PLC (AVCT:LON), 44.8 | Tethys Oil AB (0A1V:LON), 4,800
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Hardman Monthly – March 2016
Allergy Therapeutics plc (AGY:LON), 2.8 | Alliance Pharma plc (APH:LON), 35.8 | Software Circle PLC (SFT:LON), 19.0 | Lombard Risk Management (LRM:LON), 0 | Medicx Fund (MXF:LON), 0 | Murgitroyd Group (MUR:LON), 0 | PPHE Hotel Group Limited (PPH:LON), 1,452 | R.E.A. Holdings plc (RE:LON), 72.0 | Redx Pharma Plc (REDX:LON), 10.2 | Tissue Regenix Group plc (TRX:LON), 61.5 | United Cacao Ltd Sezc (CHOC:LON), 0 | Primary Health Properties PLC (PHP:LON), 93.0 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Avacta Group PLC (AVCT:LON), 44.8 | Tethys Oil AB (0A1V:LON), 4,800
- Published:
08 Mar 2016 -
Author:
Martin Hall -
Pages:
27
This month’s feature article is the first publication of the top 15 drug companies in the 2015 global industry ranking and how this has changed over the last decade. In trying to analyse the changes that have taken place, we have looked at different strategies used by management teams. Many companies are featured, but there is emphasis on GlaxoSmithKline (GSK), AstraZeneca (AZN) and Shire Pharmaceuticals (SHP). In addition, we have analysed how drugs derived from antibodies have driven market growth and now represent just over 10% of annual industry sales.